Literatur
- 1
Krahn A D, Manfreda J, Tate R B. et al .
The natural history of atrial fibrillation: Incidence, risk factors and prognosis
in the Manitoba Follow-Up Study.
Am J Med.
1995;
98
476-484
- 2
Ernst S, Kuck K-H.
Behandlung von Patienten mit Vorhofflimmern.
Clin Res Cardiol Suppl.
2006;
1
123-132
- 3
Singh B N, Singh S H. et al .
Amiodarone versus sotalol for atrial fibrillation.
N Engl J Med.
2005;
352
1861-1872
- 4
Wyse D G, Waldo A L, DiMarco J P. et al .
A comparison of rate control and rhythm control in patients with atrial fibrillation.
N Engl J Med.
2002;
347
1825-1833
- 5
Klein A L, Grimm R A. et al .
Use of transoesophageal echocardiography to guide cardioversion in patients with atrial
fibrillation.
N Engl J Med.
2001;
344
1411-1420
- 6
Ehrlich J R, Hohnlosen S H.
Medikamentöse Kardioversion von Vorhofflimmern.
Z Kardiol.
2005;
94
14-22
- 7
Reisinger J, Gatterer E, Heinze G. et al .
Prospective comparison of flecainide versus sotalol for immediate cardioversion of
atrial fibrillation.
Am J Cardiol.
1998;
81
1450-1454
- 8
Hohnloser S H, Loo A van de, Baedeker F.
Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation:
prospective comparison of soltalol vs. quinidine.
J Am Coll Cardiol.
1995;
26
852-858
- 9
Golzari H, Cebul R D, Bahler R C.
Atrial fibrillation: restoration and maintenance of sinus rhythm and indications for
anticoagulation therapy.
Ann Intern Med.
1996;
125
311-323
- 10
Coplen S E, Antman E M. et al .
Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion.
A meta analysis of randomized trials.
Circulation.
1990;
82
1106-1116
- 11
Echt D S, Liebson P R. et al, and the CAST-Investigators .
Mortality and morbidity in patients receiving encainide, flecainide or placebo. The
cardiac arrhythmia suppression trial (CAST).
N Engl J Med.
1991;
324
781-788
- 12
Lewalter T, Nickening G.
Pharmakotherapie der supraventrikulären Rhythmusstörungen.
Der Internist.
2006;
47
80-88
- 13
Murgatroyd C J, Silverman D I. et al .
Doubleblind placebocontrolled trial of digoxin in symptomatic paroxysmal atrial fibrillation.
Circulation.
1999;
99
2765-2770
- 14
Mittal S, Ayati S, Stein K M. et al .
Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic
versus damped sine wave monophasic shocks.
Circulation.
2000;
101
1282-1287
- 15
Page R L, Kerber R E, Russell J K. et al .
Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: the
results of an international randomized, double-blind multicenter trial.
J Am Coll Cardiol.
2002;
39
1956-1963
- 16
Paolo A, Giovani L. et al .
Outpatient Treatment of Recent-Onset Atrial Fibrillation with the „Pill-in-the-Pocket”
Approach.
N Engl J Med.
2004;
351
2384-2391
- 17
Lewalter T, Lüderitz B.
Vorhofflimmern - Interventionelle Differenzialtherapie unter besonderer Berücksichtigung
des Lebensalters.
Dtsch Med Wochenschr.
2005;
130
721-725
Dr. Robert Stangl
Notfallzentrum Hirslanden Bern, Salem-Spital, Klinik Beau-Site und Klinik Permanence
Schänzlistr. 39
3013 Bern, Schweiz
Email: robert.stangl@hirslanden.ch
